glucose, (beta-d)-isomer has been researched along with Escherichia coli Infections in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (42.31) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 1 (3.85) | 2.80 |
| Authors | Studies |
|---|---|
| Chiang, N; Colas, RA; Dalli, J; Orr, SK; Serhan, CN | 1 |
| Hristova, M; Ivanovska, N; Yordanov, M | 1 |
| DEDICHEN, J; LALAND, P; LALAND, S; OFTEBRO, R; THORSDALEN, N; VOSS, J | 1 |
| ZIMMERMANN, G | 2 |
| Atkinson, JP; Hourcade, DE; Mitchell, LM; Spitzer, D | 1 |
| Issekutz, AC | 1 |
| Carroll, EJ; Mueller, R; Panico, L | 1 |
| Cox, C; DeAsla, R; DeKing, D; DeLong, DJ; Goldstein, B; Kempski, MH; Lund, N; Stair, D; Tipton, RB; Woolf, PD | 1 |
| Garrison, RN; Harris, PD; Lübbe, AS | 1 |
| Barrett, JA; Boerman, OC; Corstens, FH; Edwards, DS; Oyen, WJ; van de Ven, MT; van der Laken, CJ; van der Meer, JW | 1 |
| Boerman, OC; Corstens, FH; Laverman, P; Oyen, WJ; van de Ven, MT; van der Laken, CJ; van der Meer, JW | 1 |
| Boerman, OC; Corstens, FH; Oyen, WJ; Van de Ven, MT; Van der Laken, CJ; Ven der Meer, JW | 1 |
| Hau, T; Hoffman, R; Joyce, LD; Lillehei, RC; Simmons, RL | 1 |
| Hau, T; Joyce, LD; Lillehei, RC; Simmons, RL | 1 |
| Burvenich, C; Heyneman, R; Vercauteren, R | 1 |
| Müller, E; Petzoldt, K | 1 |
| Andersen, OK; Giercksky, KE; Lundgren, TI; Revhaug, A | 1 |
| Schlegel, RJ; Ward, PA | 1 |
| Koike, K; Komatsu, N; Nagumo, N; Okubo, S | 1 |
| Adams, LG; Hanson, B; Jennings-Gee, J; Kock, ND; Saenkham, P; Subashchandrabose, S | 1 |
| Del Popolo, G; Nelli, F | 1 |
| Guan, T; He, Y; Lv, H; Su, Q | 1 |
| Neelakanta, G; Sankar, TS; Schnetz, K | 1 |
| Gao, Q; Gao, S; Ling, J; Liu, X; Wang, X; Xu, H; Xu, Y; Zhang, D | 1 |
| Feldmann, F; Hildinger, K; Schubert, S; Sorsa, LJ | 1 |
26 other study(ies) available for glucose, (beta-d)-isomer and Escherichia coli Infections
| Article | Year |
|---|---|
Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent.
Topics: Animals; Cells, Cultured; Docosahexaenoic Acids; Escherichia coli; Escherichia coli Infections; Esters; Humans; Inflammation; Lung; Macrophages; Mice; Neutrophil Infiltration; Peritonitis; Phagocytes; Phagocytosis; Receptors, G-Protein-Coupled; Reperfusion Injury; Zymosan | 2015 |
Effect of fangchinoline in murine models of multiple organ dysfunction syndrome and septic shock.
Topics: Alkaline Phosphatase; Alkaloids; Animals; Benzylisoquinolines; Complement System Proteins; Escherichia coli Infections; Liver; Macrophages, Peritoneal; Male; Mice; Mice, Inbred ICR; Multiple Organ Failure; Organ Size; Shock, Septic; Spleen; Time Factors; Tumor Necrosis Factor-alpha; Zymosan | 2003 |
A WATER-SOLUBLE POLYPEPTIDE PREPARED FROM ZYMOSAN.
Topics: Allergy and Immunology; Cell Division; Chick Embryo; Chromatography; Escherichia coli Infections; Fluorescence; Mice; Peptides; Pharmacology; Rabbits; Research; Vaccinia; Vaccinia virus; Water; Zymosan | 1963 |
[APROPOS OF THE PYROGENICITY OF ZYMOSANS].
Topics: Animals; Cattle; Escherichia coli Infections; Guinea Pigs; Horses; Lagomorpha; Mice; Pharmacology; Properdin; Pyrogens; Rabbits; Research; Zymosan | 1964 |
Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly.
Topics: Animals; Antibodies; Complement C3 Convertase, Alternative Pathway; Complement Pathway, Alternative; Escherichia coli Infections; Escherichia coli K12; Gonorrhea; Humans; Lipopolysaccharides; Mutation; Neisseria gonorrhoeae; Properdin; Protein Binding; Rabbits; Recombinant Fusion Proteins; Sheep; U937 Cells; Zymosan | 2007 |
Comparison of the effects of glucocorticoid and indomethacin treatment on the acute inflammatory reaction in rabbits.
Topics: Aging; Animals; Arthus Reaction; Escherichia coli Infections; Exudates and Transudates; Glucocorticoids; Indomethacin; Inflammation; Neutrophils; Proteins; Rabbits; Regional Blood Flow; Zymosan | 1983 |
Chemotactic factors for bovine leukocytes.
Topics: Animals; Cattle; Chemotactic Factors; Chemotaxis, Leukocyte; Edetic Acid; Endotoxins; Escherichia coli Infections; Female; Heating; In Vitro Techniques; Lipopolysaccharides; Mastitis, Bovine; Neutrophils; Peptides; Zymosan | 1982 |
Autonomic modulation of heart rate variability during endotoxin shock in rabbits.
Topics: Animals; Blood Pressure; Catecholamines; Escherichia coli Infections; Heart Rate; Male; Rabbits; Respiration; Shock, Septic; Zymosan | 1995 |
Endothelium-dependent microvascular responses to activated complement.
Topics: Animals; Arterioles; Complement Activation; Complement System Proteins; Endothelium, Vascular; Escherichia coli Infections; Hemodynamics; Hydroquinones; Male; Microcirculation; Muscle, Skeletal; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation; Zymosan | 1994 |
Technetium-99m-labeled chemotactic peptides in acute infection and sterile inflammation.
Topics: Abscess; Animals; Chemotactic Factors; Chemotaxis, Leukocyte; Escherichia coli Infections; Female; Inflammation; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Organotechnetium Compounds; Rabbits; Radionuclide Imaging; Soft Tissue Infections; Staphylococcal Infections; Technetium; Zymosan | 1997 |
In vivo expression of interleukin-1 receptors during various experimentally induced inflammatory conditions.
Topics: Animals; Candida albicans; Candidiasis; Escherichia coli Infections; Humans; Inflammation; Interleukin-1; Mice; Neutropenia; Polymerase Chain Reaction; Receptors, Interleukin-1; Recombinant Proteins; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Transcription, Genetic; Turpentine; Zymosan | 1998 |
The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation.
Topics: Animals; Antigens, CD; Escherichia coli Infections; Female; Humans; Inflammation; Interleukin-8; Iodine Radioisotopes; Neutrophils; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Interleukin; Receptors, Interleukin-8A; Recombinant Proteins; Staphylococcal Infections; Staphylococcus aureus; Tissue Distribution; Zymosan | 1998 |
Evaluation of the mechanism of zymosan-induced resistance to experimental peritonitis.
Topics: Animals; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Hemoglobins; Humans; Injections, Intraperitoneal; Leukocytes; Monocytes; Mononuclear Phagocyte System; Peritonitis; Phagocytosis; Rats; Zymosan | 1978 |
Enhancement of local immune response in the treatment of experimental peritonitis.
Topics: Animals; Ascitic Fluid; Dipeptides; Escherichia coli Infections; Leukocyte Count; Methionine; N-Formylmethionine; Peritonitis; Phagocytosis; Rats; Thioglycolates; Zymosan | 1979 |
Interaction between the respiratory burst activity of neutrophil leukocytes and experimentally induced Escherichia coli mastitis in cows.
Topics: Animals; Body Temperature; Cattle; Electrolytes; Escherichia coli Infections; Female; Heart Rate; Leukocyte Count; Mastitis, Bovine; Milk; Neutrophils; Opsonin Proteins; Oxidation-Reduction; Oxygen; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1990 |
[Animal experiment and cell biology study of Saccharomyces cerevisiae Hansen CBS 5926 in the non-specific enhancement of resistance to infection].
Topics: Animals; Bacterial Infections; Escherichia coli Infections; Female; Immunity, Innate; Immunization; Luminescent Measurements; Mice; Pneumococcal Infections; Saccharomyces cerevisiae; Zymosan | 1986 |
Metabolic burst and motility in granulocytes following trauma and endotoxinaemia in the anaesthetized pig.
Topics: Animals; Blood Pressure; Cell Movement; Escherichia coli Infections; Female; Granulocytes; Leukocyte Count; Luminescent Measurements; Male; Shock, Septic; Swine; Wounds and Injuries; Zymosan | 1986 |
Impaired leucotactic responsiveness in a child with recurrent infections.
Topics: Blood Transfusion; Chemotaxis; Child, Preschool; Escherichia coli; Escherichia coli Infections; Humans; Infections; Klebsiella; Klebsiella Infections; Male; Methods; Neutrophils; Phagocytosis; Pneumonia; Respiratory Tract Infections; Serratia marcescens; Skin Diseases, Infectious; Skin Window Technique; Staphylococcus; Zymosan | 1969 |
[Protective effect of the mushroom polysaccharide Schizophyllan against experimental bacterial infections].
Topics: Animals; Anti-Infective Agents; Basidiomycota; Escherichia coli Infections; Glycosaminoglycans; Klebsiella Infections; Male; Mice; Mononuclear Phagocyte System; Phagocytosis; Pneumococcal Infections; Proteus Infections; Pseudomonas Infections; Salmonella Infections, Animal; Staphylococcal Infections; Zymosan | 1973 |
[Properdin research. 1. Review of the properdin system and its problems; determination possibilities, assay of sera with high titer levels].
Topics: Adjuvants, Immunologic; Aluminum; Animals; Antibody Formation; Antigen-Antibody Reactions; Body Temperature; Cattle; Escherichia coli Infections; Guinea Pigs; Horses; Immunity, Active; Immunity, Maternally-Acquired; Macroglobulins; Mice; Neutralization Tests; Properdin; Rabbits; Rats; Streptomycin; Time Factors; Ultracentrifugation; Zymosan | 1972 |
Hyperglucosuria induced by dapagliflozin augments bacterial colonization in the murine urinary tract.
Topics: Animals; Benzhydryl Compounds; Escherichia coli Infections; Female; Glucosides; Mice; Mice, Inbred Strains; Urinary Tract; Urinary Tract Infections; Uropathogenic Escherichia coli | 2020 |
Recurrent bacterial symptomatic cystitis: A pilot study on a new natural option for treatment.
Topics: Adult; Aged; Benzyl Alcohols; Biological Therapy; Combined Modality Therapy; Cystitis; Escherichia coli Infections; Feasibility Studies; Female; Glucosides; Humans; Lactobacillus acidophilus; Male; Mannose; Middle Aged; Pain Measurement; Pilot Projects; Plant Extracts; Recurrence; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Tract Infections; Young Adult | 2018 |
Siderophore Biosynthesis Governs the Virulence of Uropathogenic Escherichia coli by Coordinately Modulating the Differential Metabolism.
Topics: Amino Acids; Bacterial Proteins; Carbon Cycle; Citric Acid Cycle; Enterobactin; Escherichia coli Infections; Female; Gene Deletion; Gene Expression; Glucosides; Humans; Hydroxamic Acids; Magnetic Resonance Spectroscopy; Metabolome; Oxidative Phosphorylation; Phenols; Purines; Pyrimidines; Siderophores; Thiazoles; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence | 2016 |
Characterization of a beta-glucoside operon (bgc) prevalent in septicemic and uropathogenic Escherichia coli strains.
Topics: Arbutin; Benzyl Alcohols; beta-Glucosidase; Cellobiose; Citrobacter; Cyclic AMP Receptor Protein; Enterobacter; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Glucosides; Klebsiella; Operon; Phylogeny; Repressor Proteins; Sepsis; Sequence Homology; Synteny; Urinary Tract Infections | 2009 |
Roles of iron acquisition systems in virulence of extraintestinal pathogenic Escherichia coli: salmochelin and aerobactin contribute more to virulence than heme in a chicken infection model.
Topics: Animal Structures; Animals; Chickens; Disease Models, Animal; Enterobactin; Escherichia coli; Escherichia coli Infections; Gene Deletion; Glucosides; Heme; Histocytochemistry; Hydroxamic Acids; Iron; Microscopy; Virulence Factors | 2012 |
The salmochelin siderophore receptor IroN contributes to invasion of urothelial cells by extraintestinal pathogenic Escherichia coli in vitro.
Topics: Bacterial Outer Membrane Proteins; Enterobactin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Glucosides; Receptors, Cell Surface; Urine; Urothelium | 2007 |